The Efficacy of Platelet Rich Plasma Compared With Corticosteroid Injections for the Treatment of Pain Associated With Hip Osteoarthritis
Status: Recruiting
Location: See location...
Intervention Type: Drug, Device
Study Type: Interventional
Study Phase: Phase 4
SUMMARY
Prospective, single-center that may go on to being multicenter, randomized trial comparing platelet rich plasma (PRP) versus corticosteroid injection for the treatment of symptoms of Hip osteoarthritis. The purpose of the study is to determine which therapy provides a greater reduction in patient reported outcome measures of pain and function.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 21
Maximum Age: 80
Healthy Volunteers: f
View:
• Provision of signed and dated informed consent form
• Stated willingness to comply with all study procedures and availability for the duration of the study
• Male or female, aged 21-80 years
• Radiographic diagnosis of Kellgren-Lawrence (KL) grade of II or III Hip osteoarthritis
• Indicated for a Hip injection to treat Hip OA symptoms
Locations
United States
Maryland
Sinai Hospital of Baltimore
RECRUITING
Baltimore
Contact Information
Primary
Martin Gesheff, DHSc
mgesheff@lifebridgehealth.org
410-601-9467
Time Frame
Start Date: 2024-02-21
Estimated Completion Date: 2025-12-01
Participants
Target number of participants: 54
Treatments
Experimental: Autologous Platelet Rich Plasma
\~Injection of approximately 10 mL autologous PRP Magellan Autologous Concentration System, ISTO Biologics
Active_comparator: Corticosteroid
5 milliliters (mL) injection of corticosteroid (1cc Kenalog, 4cc Xylocaine) Kenalog - 40 (triamcinolone acetonide injectable suspension, USP) Xylocaine - MPF (lidocaine HCl Injection, USP)
Related Therapeutic Areas
Sponsors
Collaborators: Hip Society
Leads: LifeBridge Health